Literature DB >> 15032554

Classification and regression trees--studies of HIV reverse transcriptase inhibitors.

M Daszykowski1, B Walczak, Q-S Xu, F Daeyaert, M R de Jonge, J Heeres, L M H Koymans, P J Lewi, H M Vinkers, P A Janssen, D L Massart.   

Abstract

In this paper, the application of Classification And Regression Trees (CART) is presented for the analysis of biological activity of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs). The data consist of the biological activities, expressed as pIC50, of 208 NNRTIs against wild-type HIV virus (HIV-1) and four mutant strains (181C, 103N, 100I, 188L) and the computed interaction energies with the Reverse Transcriptase (RT) binding pocket. CART explains the observed biological activity of NNRTIs in terms of interactions with individual amino acids in the RT binding pocket, i.e., the original data variables.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032554     DOI: 10.1021/ci034170h

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  4 in total

1.  Prediction of milk/plasma drug concentration (M/P) ratio using support vector machine (SVM) method.

Authors:  Chunyan Zhao; Haixia Zhang; Xiaoyun Zhang; Ruisheng Zhang; Feng Luan; Mancang Liu; Zhide Hu; Botao Fan
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

2.  Hybrid-genetic algorithm based descriptor optimization and QSAR models for predicting the biological activity of Tipranavir analogs for HIV protease inhibition.

Authors:  A Srinivas Reddy; Sunil Kumar; Rajni Garg
Journal:  J Mol Graph Model       Date:  2010-03-24       Impact factor: 2.518

3.  Prediction of mutagenic toxicity by combination of Recursive Partitioning and Support Vector Machines.

Authors:  Quan Liao; Jianhua Yao; Shengang Yuan
Journal:  Mol Divers       Date:  2007-04-11       Impact factor: 2.943

4.  Recursive partitioning for monotone missing at random longitudinal markers.

Authors:  Shannon Stock; Victor DeGruttola
Journal:  Stat Med       Date:  2012-09-02       Impact factor: 2.373

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.